Variant report
Variant | esv3370872 |
---|---|
Chromosome Location | chr6:69526831-69527879 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187756145 | chr6:69526852-69526853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1018436 | chr6:69526861-69526862 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs555563326 | chr6:69526869-69526870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191563510 | chr6:69526888-69526889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs646118 | chr6:69526907-69526908 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs557409371 | chr6:69526923-69526924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184233482 | chr6:69526970-69526971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545762458 | chr6:69527035-69527036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs657393 | chr6:69527084-69527085 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs569557384 | chr6:69527122-69527123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190037341 | chr6:69527128-69527129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116891643 | chr6:69527196-69527197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs70987435 | chr6:69527199-69527200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs60723627 | chr6:69527216-69527217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11755645 | chr6:69527226-69527227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192673450 | chr6:69527237-69527238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184717234 | chr6:69527240-69527241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573582367 | chr6:69527250-69527251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369117869 | chr6:69527322-69527323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373919542 | chr6:69527330-69527331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562191865 | chr6:69527354-69527355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188949337 | chr6:69527432-69527433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115621639 | chr6:69527435-69527436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140543595 | chr6:69527525-69527526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566284010 | chr6:69527536-69527537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532980737 | chr6:69527548-69527549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150464158 | chr6:69527578-69527579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73745884 | chr6:69527608-69527609 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs490653 | chr6:69527664-69527665 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs555623905 | chr6:69527670-69527671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs118118280 | chr6:69527691-69527692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538021472 | chr6:69527723-69527724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557194482 | chr6:69527732-69527733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138321794 | chr6:69527760-69527761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551837224 | chr6:69527774-69527775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552902347 | chr6:69527812-69527813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372048635 | chr6:69527829-69527830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149642157 | chr6:69527853-69527854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs492444 | chr6:69527865-69527866 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:69505600-69536000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
2 | chr6:69523000-69527400 | Weak transcription | Brain Substantia Nigra | brain |
3 | chr6:69523400-69535200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr6:69525400-69528800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:69525400-69534600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr6:69525800-69532000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr6:69527400-69528400 | Enhancers | Brain Angular Gyrus | brain |
8 | chr6:69527400-69528800 | Enhancers | Brain Substantia Nigra | brain |